Drug intelligence / Profile preview

AvailOm

Development stage
Unknown
Lead developer
Evonik
Modality
Small Molecules
Administration
Oral
01

Overview

AvailOm is an oral nutraceutical omega-3 lysine complex developed by Evonik that combines the omega-3 free fatty acids eicosapentaenoic acid and docosahexaenoic acid with L-lysine in a solid powder formulation. The complex is designed to dissociate rapidly in the stomach, releasing free fatty acids that can be absorbed without the hydrolysis step required for ethyl ester omega-3 products, which is intended to improve bioavailability. Reported biology includes cardiovascular support effects associated with omega-3 fatty acid delivery and AMPK-eNOS-mediated vasorelaxation signaling, with use positioned for heart, brain, joint, eye, and cerebrovascular health as a dietary supplement ingredient rather than a regulated pharmaceutical drug.

Brand names
AvailOm
Other names
omega-3 lysine complexomega3 lysine complexomega 3 lysine complexomega-3 free fatty acid lysine complexomega3 free fatty acid lysine complexomega 3 free fatty acid lysine complex
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)NOS3 (eNOS)

Beyond the preview

Go deeper on AvailOm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AvailOm.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call